Brigitte Uebelhart

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi request reprint [Osteoporosis]
    Brigitte Uebelhart
    Service des maladies osseuses, Département de réhabilitation et de gériatrie, HUG et Faculté de médecine, 1211 Geneve 14
    Rev Med Suisse 7:138, 140-4. 2011
  2. ncbi request reprint [Osteoporosis treatment]
    B Uebelhart
    Service des maladies osseuses, Centre collaborateur de I OMS pour la prevention de l ostéoporose, Département de réhabilitation et gériatrie, HUG, 1211 Geneve 14
    Rev Med Suisse 2:47-51. 2006
  3. ncbi request reprint [Osteoporosis]
    Brigitte Uebelhart
    Service des maladies osseuses, Centre collaborateur de l OMS pour la prévention de l ostéoporose, Département de réhabilitation et gériatrie, HUG et Faculté de médecine, 1211 Geneve 14
    Rev Med Suisse 5:124-9. 2009
  4. ncbi request reprint [Osteoporosis]
    Brigitte Uebelhart
    Service des maladies osseuses, Département des spécialités de médecine, HUG, 1211 Geneve
    Rev Med Suisse 10:101-7. 2014
  5. ncbi request reprint [Effects of bariatric surgery on bone]
    B Uebelhart
    Service des maladies osseuses, Département des spécialités de médecine HUG et Faculté de médecine, Geneve
    Rev Med Suisse 9:1251-5. 2013
  6. ncbi request reprint [Osteoporosis]
    B Uebelhart
    Service des maladies osseuses, Département des spécialités de médecine, HUG et Faculté de médecine, 1211 Geneve 14
    Rev Med Suisse 9:125-31. 2013
  7. ncbi request reprint [Osteoporosis]
    B Uelbelhart
    Service des maladies osseuses, Département des spécialités de médecine, HUG et Faculté de médecine, 1211, Geneve 14
    Rev Med Suisse 8:109-10, 112-5. 2012
  8. doi request reprint [Epidemiology and treatment of osteoporosis in men]
    Brigitte Uebelhart
    Service des maladies osseuses, Département des spécialités de médecine, et Faculté de Médecine, Hopitaux Universitaires de Geneve
    Ther Umsch 69:192-6. 2012
  9. ncbi request reprint Prophylactic injection of methylmetacrylate in vertebrae located between two previously cemented levels does not prevent a subsequent compression fracture in a patient with bone fragility
    Brigitte Uebelhart
    Service of Bone Diseases WHO Collaborating Center for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, University Hospital, 24 Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Joint Bone Spine 75:322-4. 2008
  10. ncbi request reprint [Trends in osteoporosis]
    B Uebelhart
    Service des maladies osseuses, Centre collaborateur de l OMS pour la prévention de l ostéoporose Département de réhabilitation et gériatrie, HUG, 1211 Geneve
    Rev Med Suisse 4:144-6, 148-9. 2008

Collaborators

Detail Information

Publications22

  1. ncbi request reprint [Osteoporosis]
    Brigitte Uebelhart
    Service des maladies osseuses, Département de réhabilitation et de gériatrie, HUG et Faculté de médecine, 1211 Geneve 14
    Rev Med Suisse 7:138, 140-4. 2011
    ..Cinacalcet could be used as long-term treatment in case of hyperparathyroidism. Adverse events associated with the use of bisphosphonate are still under discussion. Strontium ranelate will not be introduced in Switzerland...
  2. ncbi request reprint [Osteoporosis treatment]
    B Uebelhart
    Service des maladies osseuses, Centre collaborateur de I OMS pour la prevention de l ostéoporose, Département de réhabilitation et gériatrie, HUG, 1211 Geneve 14
    Rev Med Suisse 2:47-51. 2006
    ..Once monthly ibandronate (Bonviva) increases bone mineral density in post menopausal women with osteoporosis. Excessive suppression of bone remodelling and osteonecrosis of the yaws could be related to bisphosphonate intake...
  3. ncbi request reprint [Osteoporosis]
    Brigitte Uebelhart
    Service des maladies osseuses, Centre collaborateur de l OMS pour la prévention de l ostéoporose, Département de réhabilitation et gériatrie, HUG et Faculté de médecine, 1211 Geneve 14
    Rev Med Suisse 5:124-9. 2009
    ..Tibolone prevents fractures. Denosumab reduces the risk of vertebral, non-vertebral and hip fractures. Calcium supplementation is not associated with an increased risk of cardiovascular events...
  4. ncbi request reprint [Osteoporosis]
    Brigitte Uebelhart
    Service des maladies osseuses, Département des spécialités de médecine, HUG, 1211 Geneve
    Rev Med Suisse 10:101-7. 2014
    ..A persistent effect of zoledronic acid is observed even after one single injection. There is no increased fracture risk within 7 months following Denosumab treatment cessation...
  5. ncbi request reprint [Effects of bariatric surgery on bone]
    B Uebelhart
    Service des maladies osseuses, Département des spécialités de médecine HUG et Faculté de médecine, Geneve
    Rev Med Suisse 9:1251-5. 2013
    ..In the blood, the values of the biochemical markers of bone resorption and the parathormon are frequently increased. After bariatric surgery, the incidence of fracture is nevertheless not modified as compared to controls...
  6. ncbi request reprint [Osteoporosis]
    B Uebelhart
    Service des maladies osseuses, Département des spécialités de médecine, HUG et Faculté de médecine, 1211 Geneve 14
    Rev Med Suisse 9:125-31. 2013
    ..After 5 years treatment with denosumab, fracture incidence remains low. Atypical femoral fractures associated with bisphosphonates treatment have been evaluated in the university hospital of Geneva...
  7. ncbi request reprint [Osteoporosis]
    B Uelbelhart
    Service des maladies osseuses, Département des spécialités de médecine, HUG et Faculté de médecine, 1211, Geneve 14
    Rev Med Suisse 8:109-10, 112-5. 2012
    ..The teriparatide is effective in various bone diseases. Bazedoxifene, a new SERM is now available. A meta-analysis fails to demonstrate the effectiveness of vertebroplasty on pain relief in case of osteoporotic vertebral fractures...
  8. doi request reprint [Epidemiology and treatment of osteoporosis in men]
    Brigitte Uebelhart
    Service des maladies osseuses, Département des spécialités de médecine, et Faculté de Médecine, Hopitaux Universitaires de Geneve
    Ther Umsch 69:192-6. 2012
    ..This paper is aimed at critically discussing the various differences in osteoporosis between men and women starting with some epidemiological considerations and ending with the therapeutical aspects...
  9. ncbi request reprint Prophylactic injection of methylmetacrylate in vertebrae located between two previously cemented levels does not prevent a subsequent compression fracture in a patient with bone fragility
    Brigitte Uebelhart
    Service of Bone Diseases WHO Collaborating Center for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, University Hospital, 24 Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Joint Bone Spine 75:322-4. 2008
    ..This case report underlines the lack of a clear evaluation benefit/risk ratio of these procedures in patients with non-malignant bone fragility...
  10. ncbi request reprint [Trends in osteoporosis]
    B Uebelhart
    Service des maladies osseuses, Centre collaborateur de l OMS pour la prévention de l ostéoporose Département de réhabilitation et gériatrie, HUG, 1211 Geneve
    Rev Med Suisse 4:144-6, 148-9. 2008
    ..Despite its anti-fracture efficacy and safety, strontium ranelate is not available in Switzerland. We need strategies to improve patient's adherence to treatment in osteoporosis...
  11. ncbi request reprint [Osteoporosis treatment]
    Brigitte Uebelhart
    Service des maladies osseuses, Centre collaborateur de l OMS pour la prévention de l ostéoporose, Département de réhabilitation et gériatrie, HUG, Geneve
    Rev Med Suisse 3:150-3. 2007
    ..Alendronate (Fosavance), monthly oral and trimonthly i.v. Ibandronate (Bonviva) are the new possibilities of treatment with bisphosphonates. Yearly i.v. zoledronate injections prevent any kind of osteoporotic fractures...
  12. ncbi request reprint [Osteoporosis]
    B Uebelhart
    Service des maladies osseuses, Centre collaborateur de l OMS pour la prévention de l ostéoporose, Département de réhabilitation et de gériatrie, Hôpitaux Universitaires de Genève 1211 Genève 14
    Rev Med Suisse 1:68-71. 2005
    ..Bisphosphonates are rapidly effective to prevent fractures and with a long term efficacy. Vitamin D treatment is effective to prevent falls...
  13. ncbi request reprint [Osteoporosis and anti-androgenic therapy in case of prostate cancer]
    B Uebelhart
    Service des maladies osseuses, Centre collaborateur de I OMS pour la prevention de l ostéoporose, Département de réhabilitation et gériatrie, Hopitaux Universitaires de Geneve
    Rev Med Suisse 1:2261-2, 2264-5. 2005
    ..A fracture occurence has negative influence on survival. An antiresorptive agent like zoledronate, prevents bone loss consecutive to anti-androgenic therapy...
  14. ncbi request reprint [Osteoporosis and pain or is osteoporosis painful?]
    B Uebelhart
    Département de réhabilitation et de gériatrie, Hopitaux Universitaires de Geneve
    Rev Med Suisse 1:1662-5. 2005
    ..Pain management includes pharmacological, physio- and ergo-therapeutical measures and stabilisation maneuvers...
  15. ncbi request reprint Hormone replacement therapy: what is the evidence today?
    B Uebelhart
    Division of Bone Disease, Department of Geriatrics, University Hospital, 1211, Geneva 14, Switzerland
    Z Rheumatol 62:508-11. 2003
    ..Therefore regarding daily clinical practice, HRT certainly remains useful to control the symptoms of oestrogen deficiency in recently menopausal patients, but it should definitively no longer be recommended for long-term treatment...
  16. ncbi request reprint Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels
    Brigitte Uebelhart
    Service of Bone Diseases WHO Collaborating Center for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, University Hospital, Geneva 14 CH 1211, Switzerland
    J Bone Miner Res 19:1518-24. 2004
    ..In healthy middle-aged men, raloxifene treatment was associated with increased serum estradiol and decreased biochemical markers of bone turnover in subjects with estradiol levels below a threshold of 101.8 pM...
  17. ncbi request reprint [Osteoporosis]
    Brigitte Uebelhart
    Service des maladies osseuses, Département de réhabilitation et gériatrie, HUG et Faculté de médecine de Genève, 1211 Geneve 14
    Rev Med Suisse 6:56-60, 62. 2010
    ..Vertebroplasty is not the first line treatment for symptomatic osteoporotic vertebral fractures. Osteonecrosis of the jaw and subtrochanteric femoral fractures are still events to consider in case of treatments with bisphosphonates...
  18. pmc Effects of the SERM raloxifene on calcium and phosphate metabolism in healthy middle-aged men
    Brigitte Uebelhart
    Division of Bone Diseases WHO Collaborating Center for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
    Clin Cases Miner Bone Metab 6:163-8. 2009
    ..Conclusion. These results are compatible with the hypothesis that raloxifene is associated with lower IGF-I and 1,25(OH)(2)D(3) levels, with consequently reduced intestinal calcium absorption capacity...
  19. ncbi request reprint A rapid self-administered food frequency questionnaire for the evaluation of dietary protein intake
    Patricia Morin
    Service of Bone Diseases, WHO Collaborating Center for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, University Hospitals, Geneva, Switzerland
    Clin Nutr 24:768-74. 2005
    ..Dietary calcium and proteins are important determinants of bone health. Among the various methods to evaluate dietary intakes, food frequency questionnaires provide a self-administered, quick and simple estimation of dietary intakes...
  20. ncbi request reprint Osteoporosis in men
    R Rizzoli
    Division of Bone Diseases WHO Collaborating Center for Osteoporosis and Bone Diseases, Department of Internal Medicine, University Hospital, Geneva, Switzerland
    Nurs Clin North Am 36:467-79, ix. 2001
    ..In the management of the disease, the nurse plays a major role in the education and management of men with osteoporosis...
  21. ncbi request reprint Targeted education improves the very low recognition of vertebral fractures and osteoporosis management by general internists
    P Casez
    Service of Bone Diseases WHO Collaborating Centre for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, 24 Rue Micheli du Crest, 1211 Geneva 14, Switzerland
    Osteoporos Int 17:965-70. 2006
    ..Radiologists did not receive this educational strategy and served as controls...
  22. ncbi request reprint [Hormone replacement therapy and SERMs in the prevention and treatment of osteoporosis]
    Daniel Wirthner
    Département de gynécologie obstétrique, CHUV, Lausanne
    Rev Med Suisse Romande 124:424-6. 2004